AI assistant
ACHIEVE LIFE SCIENCES, INC. — Director's Dealing 2009
Feb 2, 2009
33882_dirs_2009-02-02_475685ac-f974-4f16-9684-a2a60946f0c2.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4/A — Form 4/A
Issuer: ONCOGENEX PHARMACEUTICALS, INC. (OGXI)
CIK: 0000949858
Period of Report: 2008-08-21
Reporting Person: Anderson Stephen Charles (CFO and Secretary)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2008-08-21 | stock option (right to buy) | $4.1051 | A | 21776 | Acquired | 2013-03-23 | Common Stock (21776) | Direct |
Footnotes
F1: Due to administrative error, the original Form 4 overstated the exercise price by $0.0026.
F2: Due to an administration error, the original Form 4 understated the number of shares subject to the stock option by 13.
F3: 16,332 shares underlying stock option were exercisable on 08/21/2008; 5,444 shares underlying stock option were exercisable on 01/09/2009.
F4: Received in exchange for a stock option to acquire 100,000 shares of Oncogenex Technologies Inc. ("Oncogenex Technologies") common stock for CAD$0.95 per share in connection with an arrangement between Oncogenex Technologies and Oncogenex Pharmaceuticals, Inc.